William Warren

2PUBLICATIONS
0CO-AUTHORS
Toxicology (incl. clinical toxicology)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Apr 15, 2026
Evaluating FABP5 as a Therapeutic Target for Pain Management.

William Warren, Myles Osborn, Martin Kaczocha

|Aug 27, 2024
ART26.12, a novel fatty acid-binding protein 5 inhibitor, shows efficacy in multiple preclinical neuropathy models.

W G Warren, M Osborn, A David-Pereira

Pageof 1

Frequent Collaborators